MetaVia Inc. — Director's Dealing 2017

Aug 15, 2017

SEC Form 4/A — Form 4/A

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2017-08-10

Reporting Person: MATHIESEN JEFFREY S (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-10	Common Stock	M	3000	$3.59	Acquired	10927	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-10	Employee Stock Option (right to buy)	$3.59	M	3000	Disposed	2025-09-24	Common Stock (3000)	Direct

Footnotes

F1: Amended to correct an error related to the number of shares subject to the reported option following the exercise.